MedDataX Logo

The Role of Electroacupuncture With Standard Therapy on Sperm Analysis and SOD Levels in Oligozoospermia.

NCT ID: NCT06088693

Last Updated: 2023-12-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-11

Study Completion Date

2023-12-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to compare in Oligozoospermia Patient. The main questions it aims to answer are: 1. Electroacupuncture therapy and standard therapy can affect oligozoospermia. 2. Electroacupuncture therapy and standard therapy can affect semen and spermatozoa plasma SOD levels.

Researchers will compare patient with standard therapy with patient with standard therapy with electroacupuncture.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. Male subjects aged more than 25 years and less than 45 years.
2. Oligozoospermia according to the 2010 WHO criteria is mild (10-15 million spermatozoa/mL), moderate (5-10 million spermatozoa/mL) and severe (\<5 million spermatozoa/mL).
3. Willing to take part in research and sign informed consent.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Oligozoospermia Oligoasthenozoospermia Oligoasthenoteratozoospermia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Outcome Assessors
The investigator blind the participant allocation

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

Patients diagnosed with Oligozoospermia who only receive standard therapy from an Andrologist as a standard therapy.

Group Type NO_INTERVENTION

No interventions assigned to this group

Intervention

Patients diagnosed with Oligozoospermia receive standard therapy from an Andrologist and Electroacupuncture.

Group Type EXPERIMENTAL

Electroacupuncture and Standard Therapy

Intervention Type OTHER

Acupuncture Needle Insertion with Electroacupuncture machine.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Electroacupuncture and Standard Therapy

Acupuncture Needle Insertion with Electroacupuncture machine.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male 25 to 45 years old.
* Oligozoospermia according to the 2010 WHO criteria is mild (10-15 million spermatozoa/mL), moderate (5-10 million spermatozoa/mL) and severe (\<5 million spermatozoa/mL).
* Willing to participate in research and sign informed consent.

Exclusion Criteria

* Emergency case patient / bleeding disorders
* Have a tumor, scar tissue or infected wound in the area where the acupuncture needle will be inserted.
* Alcoholic
* Using a pacemaker (heart pacemaker).
* Azoospermia
* Varicocele
Minimum Eligible Age

25 Years

Maximum Eligible Age

45 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Indonesia University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lisa Yunita

Medical Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lisa Yunita

Role: PRINCIPAL_INVESTIGATOR

Indonesia University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Lisa Yunita

Jakarta, Jakarta Timur, Indonesia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Indonesia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

23-06-1010

Identifier Type: -

Identifier Source: org_study_id